Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application

Belen Alvarez-Palomo, Joaquim Vives, Ricardo P. Casaroli-Marano, Susana G. Gomez, Luciano Rodriguez Gomez, Michael J. Edel, Sergi Querol Giner

Research output: Contribution to journalReview article

Abstract

In this article, we will discuss the main aspects to be considered to define standard operation procedures (SOPs) for the creation of an induced pluripotent stem cell (iPSC) bank using cord blood (CB)or similar cell typebank guidelines for clinical aims. To do this, we adapt the pre-existing SOP for CB banking that can be complementary for iPSCs. Some aspects of iPSC manufacturing and the particular nature of these cells call for special attention, such as the potential multiple applications of the cells, proper explanation to the donor for consent of use, the genomic stability and the risk of genetic privacy disclosure. Some aspects of the iPSC SOP are solidly established by CB banking procedures, other procedures have good consensus in the scientific and medical community, while others still need to be further debated and settled. Given the international sharing vocation of iPSC banking, there is an urgent need by scientists, clinicians and regulators internationally to harmonize standards and allow future sample interchange between many iPSC bank initiatives that are springing up worldwide.

Original languageEnglish
Article number476
Number of pages15
JournalJournal of Clinical Medicine
Volume8
Issue number4
DOIs
Publication statusPublished - Apr 2019

Cite this

Alvarez-Palomo, Belen ; Vives, Joaquim ; Casaroli-Marano, Ricardo P. ; Gomez, Susana G. ; Rodriguez Gomez, Luciano ; Edel, Michael J. ; Querol Giner, Sergi. / Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application. In: Journal of Clinical Medicine. 2019 ; Vol. 8, No. 4.
@article{337408ff26a442ab98203e2a5e3e4391,
title = "Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application",
abstract = "In this article, we will discuss the main aspects to be considered to define standard operation procedures (SOPs) for the creation of an induced pluripotent stem cell (iPSC) bank using cord blood (CB)or similar cell typebank guidelines for clinical aims. To do this, we adapt the pre-existing SOP for CB banking that can be complementary for iPSCs. Some aspects of iPSC manufacturing and the particular nature of these cells call for special attention, such as the potential multiple applications of the cells, proper explanation to the donor for consent of use, the genomic stability and the risk of genetic privacy disclosure. Some aspects of the iPSC SOP are solidly established by CB banking procedures, other procedures have good consensus in the scientific and medical community, while others still need to be further debated and settled. Given the international sharing vocation of iPSC banking, there is an urgent need by scientists, clinicians and regulators internationally to harmonize standards and allow future sample interchange between many iPSC bank initiatives that are springing up worldwide.",
keywords = "SOP, cord blood bank, induced pluripotent stem cells, cell therapy, advanced therapies medicinal products, HLA haplobank, LINES, TRANSPLANTATION, PROJECT, GENERATION, CHALLENGES, CONSENT, POINTS, IPSC",
author = "Belen Alvarez-Palomo and Joaquim Vives and Casaroli-Marano, {Ricardo P.} and Gomez, {Susana G.} and {Rodriguez Gomez}, Luciano and Edel, {Michael J.} and {Querol Giner}, Sergi",
year = "2019",
month = "4",
doi = "10.3390/jcm8040476",
language = "English",
volume = "8",
journal = "Journal of Clinical Medicine",
issn = "2077-0383",
publisher = "MDPI AG",
number = "4",

}

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application. / Alvarez-Palomo, Belen; Vives, Joaquim; Casaroli-Marano, Ricardo P.; Gomez, Susana G.; Rodriguez Gomez, Luciano; Edel, Michael J.; Querol Giner, Sergi.

In: Journal of Clinical Medicine, Vol. 8, No. 4, 476, 04.2019.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application

AU - Alvarez-Palomo, Belen

AU - Vives, Joaquim

AU - Casaroli-Marano, Ricardo P.

AU - Gomez, Susana G.

AU - Rodriguez Gomez, Luciano

AU - Edel, Michael J.

AU - Querol Giner, Sergi

PY - 2019/4

Y1 - 2019/4

N2 - In this article, we will discuss the main aspects to be considered to define standard operation procedures (SOPs) for the creation of an induced pluripotent stem cell (iPSC) bank using cord blood (CB)or similar cell typebank guidelines for clinical aims. To do this, we adapt the pre-existing SOP for CB banking that can be complementary for iPSCs. Some aspects of iPSC manufacturing and the particular nature of these cells call for special attention, such as the potential multiple applications of the cells, proper explanation to the donor for consent of use, the genomic stability and the risk of genetic privacy disclosure. Some aspects of the iPSC SOP are solidly established by CB banking procedures, other procedures have good consensus in the scientific and medical community, while others still need to be further debated and settled. Given the international sharing vocation of iPSC banking, there is an urgent need by scientists, clinicians and regulators internationally to harmonize standards and allow future sample interchange between many iPSC bank initiatives that are springing up worldwide.

AB - In this article, we will discuss the main aspects to be considered to define standard operation procedures (SOPs) for the creation of an induced pluripotent stem cell (iPSC) bank using cord blood (CB)or similar cell typebank guidelines for clinical aims. To do this, we adapt the pre-existing SOP for CB banking that can be complementary for iPSCs. Some aspects of iPSC manufacturing and the particular nature of these cells call for special attention, such as the potential multiple applications of the cells, proper explanation to the donor for consent of use, the genomic stability and the risk of genetic privacy disclosure. Some aspects of the iPSC SOP are solidly established by CB banking procedures, other procedures have good consensus in the scientific and medical community, while others still need to be further debated and settled. Given the international sharing vocation of iPSC banking, there is an urgent need by scientists, clinicians and regulators internationally to harmonize standards and allow future sample interchange between many iPSC bank initiatives that are springing up worldwide.

KW - SOP

KW - cord blood bank

KW - induced pluripotent stem cells

KW - cell therapy

KW - advanced therapies medicinal products

KW - HLA haplobank

KW - LINES

KW - TRANSPLANTATION

KW - PROJECT

KW - GENERATION

KW - CHALLENGES

KW - CONSENT

KW - POINTS

KW - IPSC

U2 - 10.3390/jcm8040476

DO - 10.3390/jcm8040476

M3 - Review article

VL - 8

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

SN - 2077-0383

IS - 4

M1 - 476

ER -